Home›Search›Rheumatology and Therapy

Rheumatology and Therapy

Adis International Ltd · United Kingdom · Est. 1992

ISSN2198-6576eISSN2198-6584

SJR Q2✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

109

days submission → published

measured · last 19 articles · accept 82d

weeks to publish · journal-reported

Fast · vs ~15 wk median

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.991

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.998

Total Worksi

846

Total Citationsi

13,992

2yr Mean Citednessi

2.72

Open Impact Factor alternative

Aims & Scope

Rheumatology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal, dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of therapies for rheumatic diseases. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1992

FrequencyTwo Issues A Year, 2015-

StatusActive (last: 2026)

Total Publications846

Publisher OrgAdis, Springer Healthcare

OA Since2013

Visit Journal Website

Submission Info

APC Cost$7,675Above median

Peer ReviewSingle-blind

Review Time~6 weeks

Acceptance Rate—

OA LicenseCC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

LOCKSSPorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

11/12 · 92%

✅

Do you know the journal / publisher?

Adis International Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2198-6576 / 2198-6584

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

$7,675

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

LOCKSS, Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.5k

2019

2.9k

2020

142

2.3k

2021

104

1.3k

2022

107

866

2023

106

550

2024

173

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Immunology and AllergyQ2

RheumatologyQ2

Subject Classification

Web of Science Categories

Rheumatology

Scopus Categories

RheumatologyImmunology and Allergy

Research Topics (OpenAlex)

Rheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsPsoriasis: Treatment and PathogenesisAutoimmune and Inflammatory Disorders ResearchSystemic Lupus Erythematosus ResearchBiosimilars and Bioanalytical MethodsGout, Hyperuricemia, Uric AcidOsteoarthritis Treatment and MechanismsSpine and Intervertebral Disc PathologySystemic Sclerosis and Related Diseases

Frequently asked questions about Rheumatology and Therapy

Is Rheumatology and Therapy a predatory journal?

PubScope has no integrity flags on record for Rheumatology and Therapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Rheumatology and Therapy?

Rheumatology and Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.72.

Is Rheumatology and Therapy indexed in Scopus and Web of Science?

Rheumatology and Therapy is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Rheumatology and Therapy?

How much does it cost to publish in Rheumatology and Therapy?

Rheumatology and Therapy charges an article processing charge (APC) of about $7,675 for open-access publication.